Although the presence of lymphocytes in the tumor microenvironment (TME), in particular CD8+T cells, is correlated with good prognosis in several solid tumors, these CD8+ tumor infiltrating lymphocytes (TILs) fail to effectively eliminate tumor cells and infrequently provide protective immunity [2]. The gene discussed is CD8A; the disease is neoplasm.